Head and Neck Cancer

ASCO | ASCO Cancer Foundation | Journal of Clinical Oncology | Journal of Oncology Practice

Oncologist-approved cancer information from the American Society of Clinical Oncology

Home

Cancer News and Meetings

ASCO Annual Meetings

Head and Neck Cancer

Head and Neck Cancer

News and highlights from ASCO Annual Meetings.

Category :

Year :

Study Shows Increased Survival for Patients With HPV-Related Oropharyngeal Cancer
May 14, 2009

Researchers found that people with stage III or IV oropharyngeal cancer (cancer of the upper throat) who have tumors containing the human papillomavirus (HPV) live longer.

Cetuximab Added to Chemotherapy Helps Patients With Head and Neck Cancers Live Longer
June 2, 2007

Adding the drug cetuximab (Erbitux) to chemotherapy for the initial treatment of head and neck cancer that is metastatic (has spread to other areas of the body) or recurrent (has come back after treatment) extends patients' lives, according to a new study. Most patients in the study had cancers of the larynx (voice box) or pharynx (throat).

Adding Docetaxel to Standard Treatment for Advanced Head and Neck Cancer Lowers Risk of Death
June 4, 2006

Findings from a clinical trial show that induction chemotherapy (chemotherapy that is given before other treatment) with docetaxel (Taxotere), cisplatin (Platinol), and fluorouracil (5-FU) reduces the risk of death by 30% for patients with advanced head and neck cancer. Patients were then given weekly chemotherapy together with radiation therapy (chemoradiotherapy) to complete their treatment. This treatment program is referred to as sequential therapy.

New Advances in Aerodigestive Cancers
May 18, 2002
Studies examining new treatments for aerodigestive cancers will be discussed at a press conference at the 38th Annual Meeting of the American Society of Clinical Oncology.